Mobile phone-based screening for anemia in young children in western Kenya

基于手机的肯尼亚西部幼儿贫血筛查

基本信息

  • 批准号:
    10752968
  • 负责人:
  • 金额:
    $ 38.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-21 至 2025-08-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Anemia is a common, serious, and neglected global public health problem, affecting over 2 billion people with especially high prevalence among children in low-and middle-income countries (LMICs). Unfortunately, despite the high prevalence and negative health consequences of anemia, few routine screening programs exist in LMICs. There is a critical need to identify an easy-to-implement, low-cost strategy to screen and treat anemia and its causes in LMICs, where > 50% of the population and as many as 75% of children under-5 years of age suffer from anemia. In many LMICs, anemia goes undiagnosed, primarily due to lack of access to accurate and affordable laboratory diagnostics. The most common global causes of anemia (iron deficiency, malaria, sickle cell disease) are relatively easy to diagnose with highly effective treatments. Children with chronic illnesses such as HIV are at an even higher risk of anemia with a significant impact on health outcomes. In most high-income countries, infants are universally screened at birth for sickle cell disease and are routinely screened for anemia at least once in early childhood. This screening and treatment paradigm is highly effective and averts the significant morbidity and early mortality associated with anemia. In LMICs, although >50% of children are anemic, there is no systematic screening and limited capacity to diagnose sickle cell disease, iron deficiency, or other underlying causes of anemia when it is detected. The lack of diagnostic laboratory capacity to measure hemoglobin concentration accurately and affordably is a primary limitation to the systematic identification of anemia. In this study, we will use a smartphone-based, noninvasive method to measure hemoglobin and detect anemia by analyzing photos of the palpebral conjunctiva. This smartphone-based method has been shown to accurately measure hemoglobin in a controlled setting in the US but has not been rigorously evaluated in settings where more severe anemia is common. In this study, we will evaluate the utility and accuracy of this mobile health (mHealth) tool to diagnose anemia among young children in western Kenya. Through the R21 phase, we will (Aim 1) develop a community advisory board to proactively consider acceptability and feasibility of this screening intervention and develop an implementation plan and (Aim 2) evaluate the diagnostic accuracy of this mHealth tool in detecting anemia among Kenyan children who are HIV-exposed and unexposed, within the context of multiple etiologies of anemia. If found to be valid, use of this anemia screening tool will be integrated into the health system, according to the implementation plan developed by the Community Advisory Board. We will measure implementation outcomes of the screening program and prospectively evaluate a disease-specific follow-up and treatment plan to assess the clinical impact of this mHealth-based anemia screening and treatment program for children living in western Kenya. This research has important implications to demonstrate the feasibility of an mHealth anemia screening tool and will address a critical gap towards addressing the neglected global burden of anemia.
项目总结/摘要 贫血是一种常见、严重和被忽视的全球公共卫生问题,影响着20多亿人, 特别是在低收入和中等收入国家(LMIC)的儿童中,不幸的是,尽管 由于贫血的高患病率和负面健康后果, 中低收入国家。迫切需要确定一种易于实施、低成本的策略来筛查和治疗贫血 在中低收入国家,超过50%的人口和多达75%的5岁以下儿童 患有贫血症。在许多低收入国家,贫血得不到诊断,主要是因为缺乏准确和有效的诊断方法。 负担得起的实验室诊断。全球最常见的贫血原因(缺铁、疟疾、镰刀 细胞疾病)相对容易用高效的治疗方法诊断。患有慢性疾病的儿童, 因为艾滋病毒感染者患贫血的风险更高,对健康结果有重大影响。在大多数高收入 在一些国家,婴儿在出生时普遍接受镰状细胞病筛查,并定期接受贫血筛查。 至少在童年早期有一次。这种筛查和治疗模式非常有效, 与贫血相关的显著发病率和早期死亡率。在中低收入国家,尽管>50%的儿童贫血, 没有系统的筛查,诊断镰状细胞病、缺铁或其他疾病的能力有限。 贫血的根本原因,当它被发现。缺乏诊断实验室能力, 血红蛋白浓度的准确性和经济性是系统识别的主要限制。 贫血在这项研究中,我们将使用一种基于智能手机的非侵入性方法来测量血红蛋白并检测 贫血通过分析照片的睑结膜。这种基于智能手机的方法已被证明 在美国的受控环境中准确测量血红蛋白,但尚未在环境中进行严格评估 在那里更严重的贫血很常见。在这项研究中,我们将评估这种移动的的实用性和准确性 健康(mHealth)工具来诊断肯尼亚西部幼儿的贫血。在R21阶段,我们 我会(目标1)成立一个社区咨询委员会,积极考虑这项建议的可接受性和可行性 筛选干预,并制定实施计划,并(目标2)评估诊断的准确性, 移动健康工具,用于检测肯尼亚艾滋病毒感染和未感染儿童的贫血症, 贫血的多种病因背景。如果发现有效,将整合使用此贫血筛查工具 根据社区咨询委员会制定的实施计划,将这一方案纳入卫生系统。我们 将衡量筛查计划的实施结果,并前瞻性地评估疾病特异性 随访和治疗计划,以评估这种基于mHealth的贫血筛查和治疗的临床影响 为生活在肯尼亚西部的儿童提供的项目。这项研究具有重要的意义,以证明 一个移动健康贫血筛查工具的可行性,并将解决一个关键的差距,解决被忽视的 全球贫血负担。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Patrick Thomas McGann其他文献

Patrick Thomas McGann的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Patrick Thomas McGann', 18)}}的其他基金

Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa
在非洲精准推广羟基脲的利用和安全
  • 批准号:
    10209231
  • 财政年份:
    2021
  • 资助金额:
    $ 38.32万
  • 项目类别:
Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa
在非洲精准推广羟基脲的利用和安全
  • 批准号:
    10675756
  • 财政年份:
    2021
  • 资助金额:
    $ 38.32万
  • 项目类别:
Therapeutic Response Evaluation and Adherence Trial: A Prospective Study of Hydroxyurea for Children with Sickle Cell Anemia
治疗反应评估和依从性试验:羟基脲治疗镰状细胞性贫血儿童的前瞻性研究
  • 批准号:
    9285876
  • 财政年份:
    2015
  • 资助金额:
    $ 38.32万
  • 项目类别:
Therapeutic Response Evaluation and Adherence Trial: A Prospective Study of Hydroxyurea for Children with Sickle Cell Anemia
治疗反应评估和依从性试验:羟基脲治疗镰状细胞性贫血儿童的前瞻性研究
  • 批准号:
    9130250
  • 财政年份:
    2015
  • 资助金额:
    $ 38.32万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 38.32万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.32万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 38.32万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.32万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 38.32万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.32万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 38.32万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 38.32万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 38.32万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.32万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了